Archive for February, 2012

Mimosa Pudica, herb described by Dr. Klinghardt, is back in stock!

Mimosa PudicaMany people are now aware of Mimosa Pudica, an ayurvedic herb recommended by Dr. Klinghardt for parasites and possibly Babeisa.

According to Scott Forsgren’s notes on the Deep Look Beyond Lyme conference which took place in 2011, Dr. Klinghardt says that Mimosa Pudica is 30 times stronger than the best pharmaceutical drug.

The problem has been getting the stuff. Various reports across the web indicate that some sources may be low-quality and cause side effects or sickness. The most reliable source, according to some, is Hopkinton Drug, a compounding pharmacy in Massachusetts. However, due to high demand, this pharmacy had been out of stock for several months. Yesterday I spoke with someone at the pharmacy and I am pleased to report that the product is back in stock. Furthermore, it is available OTC (over the counter) at a price which is much lower than I’ve previously seen. You can contact Hopkinton Drug at (508) 435-4441 ext. 117 or ext. 118, or email them at support@rxandhealth.com.

Related: Don’t miss Hopkinton Drug’s Top 3 Lyme Disease Formulations (PDF flyer).

There have been various studies done on this species of plant and its various effects, including studies on antimicrobial effects, and anti-anxiety effects.  Please note, though, that this product is still experimental and that conclusive results about its usefulness and safety are still being evaluated by LLMDs.

Does the herb work? I’m in touch with one person who says they feel much better when taking it. However, I think it is too early to draw conclusions. I hope people report their results on this blog, so we can compile some user experiences.

If you use this product, please report your results here on this blog, so that others can learn from your experience. Also, please only use this product under the supervision of a licensed physician. For dosing information, please consult a physician who is experienced with using Mimosa Pudica. DISCLOSURE: Hopkington Drug is an advertising partner with BioMed Publishing Group, the publisher of this blog.